

Cover Story
																																	Free
											By Matthew Bin Han Ong
NIH, NCI and FDA should receive budget increases of at least 7 percent a year, the 2015 Cancer Progress Report by the American Association for Cancer Research recommends.
In Brief


Drugs & Targets


Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC
 ctMoniTR project aims to improve efficiency in development of intermediate endpoints
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
 
            









